Altimmune's existence depends almost entirely on the outcome of the Phase 2 trial for pemvidutide in MASH. Learn why ALT ...
Adding probiotics to antipsychotic treatment is associated with a significant decrease in schizophrenia symptoms, a new ...
Targeted Variable Analysis: Identify hard-to-detect combinations ... Delivering Key Benefits for Your Trials Enhanced Efficacy: Optimize key clinical endpoints with high effect-size models for ...
6d
TipRanks on MSNNetraMark Unveils NetraAI 2.0: Revolutionizing Clinical Trial AnalysisNetraMark Holdings ( ($TSE:AIAI) ) just unveiled an update. NetraMark has announced the launch of NetraAI 2.0, an advanced platform aimed at ...
At the Envision Summit 2025 in San Juan, Puerto Rico, Deepak Sambhara, MD, gave insight into the 96-week post hoc fluid ...
Rezolute , Inc. (NASDAQ:RZLT), a clinical-stage biopharmaceutical company, is making significant strides in the development ...
4h
News Medical on MSNNerinetide shows promise in stroke treatment meta-analysisThe Calgary Stroke Program, a joint University of Calgary and Alberta Health Services initiative at Foothills Medical Centre, has been involved with three papers published this week in The Lancet and ...
The "Sinusitis Pipeline Insight Analysis Report" drug pipelines has been added to ResearchAndMarkets.com's offering.The sinusitis treatment pipeline analysis provides an overview of recent ...
By transforming clinical trial data into actionable insights ... by assessing stability and variability across patient populations. Targeted Variable Analysis: Identify hard-to-detect combinations of ...
Targeted Variable Analysis: Identify hard-to-detect combinations of key ... Delivering Key Benefits for Your Trials Enhanced Efficacy: Optimize key clinical endpoints with high effect-size models for ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results